Who Paid My Doc
foresiGHt
ClinicalTrials.gov NCT04615273
Research payments
$2,541,292
Through program year 2025, $2,541,292 in research payments was reported against foresiGHt, across 275 payments, paid by Ascendis Pharma, Inc..
- Paid by
- Ascendis Pharma, Inc.
- ClinicalTrials.gov
- NCT04615273
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $3,437 | 1 |
| 2024 | Research | $297,518 | 50 |
| 2023 | Research | $1,296,511 | 76 |
| 2022 | Research | $943,826 | 148 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Maria Fleseriu Portland, OR Named on 33 payments
- Nidhi Agrawal New York, NY Named on 22 payments
- Lisa Abbott Reno, NV Named on 14 payments
- Oksana Hamidi Dallas, TX Named on 13 payments
- Beverly Biller Charlestown, MA Named on 12 payments
- Christina Wang Torrance, CA Named on 12 payments
- Laurence Katznelson Stanford, CA Named on 10 payments
- Irina Bancos Rochester, MN Named on 9 payments
- Georgiana Dobri Cleveland Heights, OH Named on 9 payments
- Kevin Yuen Phoenix, AZ Named on 8 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.